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Abstract
Background: The M5 muscarinic acetylcholine receptor is known to play a crucial role in mediating acetylcholine dependent
dilation of cerebral blood vessels. Previously, we reported that male M5 muscarinic acetylcholine knockout mice (M5R
2/2
mice) suffer from a constitutive constriction of cerebral arteries, reduced cerebral blood flow, dendritic atrophy, and short-
term memory loss, without necrosis and/or inflammation in the brain.
Methodology/Principal Findings: We employed the Magnetic Resonance Angiography to study the area of the basilar
artery in male and female M5R
2/2 mice. Here we show that female M5R
2/2 mice did not show the reduction in vascular area
observed in male M5R
2/2 mice. However, ovariectomized female M5R
2/2 mice displayed phenotypic changes similar to
male M5R
2/2 mice, strongly suggesting that estrogen plays a key role in the observed gender differences. We found that
17b-estradiol (E2) induced nitric oxide release and ERK activation in a conditional immortalized mouse brain cerebrovascular
endothelial cell line. Agonists of ERa,E R b, and GPR30 promoted ERK activation in this cell line. Moreover, in vivo magnetic
resonance imaging studies showed that the cross section of the basilar artery was restored to normal in male M5R
2/2 mice
treated with E2. Treatment with E2 also improved the performance of male M5R
2/2 mice in a cognitive test and reduced the
atrophy of neural dendrites in the cerebral cortex and hippocampus. M5R
2/2 mice also showed astrocyte swelling in cortex
and hippocampus using the three-dimensional reconstruction of electron microscope images. This phenotype was reversed
by E2 treatment, similar to the observed deficits in dendrite morphology and the number of synapses.
Conclusions/Significance: Our findings indicate that M5R
2/2 mice represent an excellent novel model system to study the
beneficial effects of estrogen on cerebrovascular function and cognition. E2 may offer new therapeutic perspectives for the
treatment of cerebrovascular insufficiency related memory dysfunction.
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Introduction
Cholinergic pathways have been shown to play an important role
in the regulation of cerebral vascular resistance, relaxation and
contraction of blood vessels, and regional blood flow [1–3]. It is well
known that acetylcholine (Ach) is a powerful dilator of mostvascular
beds and that this activity is mediated by endothelial muscarinic
Achreceptorstriggering the release of the actualvasorelaxing agent,
nitric oxide (NO) [4–8]. In a previous study, we demonstrated that
M5 receptors (M5R) mediate Ach-induced relaxation of cerebral
but not of peripheral blood vessels [9], consistent with immunohis-
tochemical [10] and pharmacological studies [11,12].
Ach binding to M5Rs leads to the activation of G proteins of the
Gq family which in turns triggers increases in intracellular calcium
and inositol 1,4,5-triphosphate levels [13–16] and eventually the
activationofendothelialNOsynthase(eNOS)andtheproduction of
NO[12].Therefore,the constitutiveconstrictionofcerebralarteries
in male M5R
2/2 mice that we observed in a previous study [17] is
most likely due to the lack of Ach-mediated NO release.
We previously reported that male M5R knockout (M5R
2/2)
mice show a constitutive decrease in the diameter of the basilar
artery and of middle cerebral arterioles, a reduction in cerebral
blood flow (CBF), and impaired autoregulation of CBF, as
compared to wildtype littermates [17]. Male M5R
2/2 mice also
displayed dendritic atrophy in the cerebral cortex and hippocam-
pus and impaired function of CA3 hippocampal pyramidal cells,
probably secondary to cerebrovascular insufficiency [17]. More-
over, deficits in short-term memory (Y-maze) and cognitive
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2/2 mice,
consistent with impaired hippocampal function [17]. These data
suggest that male M5R
2/2 mice are a suitable model for
evaluating the effect of decreased CBF on neurologic function.
Numerous animal models of chronic cerebral hypoperfusion have
been generated by surgical methods. For example, one of these
models showed white matter lesions, glial activation, and spatial
memory deficits, mimicking several pathological aspects of human
ischemia [18,19]. Male M5R
2/2 mice show also prolonged
chronic cerebral hypoperfusion without necrosis in brain [17].
In the present study, we show that the phenotypic changes
displayed by the male M5R
2/2 mice were absent in female
M5R
2/2 mice. One possibility is that estrogens, the primary
female sex hormones, protect female M5R
2/2 mice against the
detrimental effects associated with the lack of M5Rs in males.
Consistent with this notion, several studies have shown that
estrogen increases CBF by stimulating the release of NO from
vascular endothelial cells [20].
To test the hypothesis that estrogen protects against cerebro-
vascular and neuronal deficits caused by the absence of M5Rs, we
conducted phenotyping studies with male M5R
2/2 mice bearing
estrogen (E2) implants. We found that E2 treatment fully restored
the diameter of the basilar artery to normal in male M5R
2/2
mice. Furthermore, treatment of male M5R
2/2 mice with
estrogen also improved their cognitive performance in a Y-maze
test and reduced the atrophy of neural dendrites in the cerebral
cortex and hippocampus.
This study demonstrates that male M5R
2/2 mice, but not
female M5R
2/2 mice, show a significantly increased number of
GFAP positive cells in cortex and hippocampus, but the number of
S100b positive astrocytes, a measure of the total number of
astrocytes, remain unchanged. These astrocytic responses are
unlikely associated with neural cells death or immunoglobulin
leakage around cerebral blood vessels. This observation suggests
that the lack of M5R in male mice leads to astrocytic swelling in
cortex and hippocampus. Interestingly, E2 treatment of male
M5R
2/2 mice completely restored normal GFAP expression levels
in hippocampus. These findings indicate that M5R
2/2 mice
represent an excellent novel model system to study the beneficial
effects of estrogen on cerebrovascular function and cognition.
Results
Gender difference of CBF in M5R
2/2 mice
We employed the Magnetic Resonance Angiography (MRA)
based time-of flight (TOF) method to study the area of the basilar
artery in male and female M5R
+/+ and M5R
2/2 mice. Ovariecto-
mies were performed 4 month after birth using standard surgical
procedures. To synchronize menstrual cycle length, we inject
pregnant mare serum gonadotropin (PMSG) / human chorionic
gonadotropin (hCG)into femalemice by intraperitoneal injection (IP)
before E2 treatment (see Material and Method section). MRA was
carried out 2 week after ovariectomy (OVX) surgery and two days
after PMSG/hCG treatments on 4 month-old female M5R
+/+
(n=11) and M5R
2/2 mice (n=12). TOF angiograms were obtained
using a two-dimensional gradient-echo sequence (for additional
experimental details, see Materials and methods). Three-dimensional
angiograms of the MCA and the basilar artery (the segments
indicated in Figure 1A) were obtained by using MATLAB software.
Figure 1A shows that the diameter of the MCA and the basilar artery
was similar in female M5R
+/+ and M5R
2/2 mice. In contrast,
ovariectomized female M5R
2/2 mice showed a significant decrease
in vascular diameter in the MCA and the basilar artery, as compared
to intact female M5R
2/2 mice (Figure 1A).
For CBF measurements, we defined the branches of the MCA
in the order from A1 to A3 (data not shown) and previously
described in [17]. We measured the CBF of cerebral arterioles
located on the cortical surface at the level of the peripheral branch
of the MCA in male M5R
+/+ and M5R
2/2 mice (4-month-old)
using laser-Doppler flowmeter. Under resting conditions, male
M5R
2/2 mice showed a significantly lower (p,0.001) CBF than
male M5R
+/+ mice at the A1 branch (see Supporting Information,
Figure S1). However, female M5R
2/2 mice did not show any
significant impairment in CBF, as compared to female M5R
+/+
mice (Figure S1). Furthermore, OVX M5R
2/2 mice showed
impaired CBF (p,0.001), similar to male M5R
2/2 mice (Figure
S1), suggesting that female sex hormones, such as estrogen, may
be able to compensate for the impairment of cerebrovascular
function caused by the lack of M5Rs in male mice.
Neuroanatomical and cognitive phenotypes of female
and OVX female M5R
2/2 mice
Male M5R
2/2 mice showed a significantly reduced number of
dendritic spines in cortical and hippocampal CA3 pyramidal
neurons [17]. We therefore also examined the number of
dendritic spines in cortical pyramidal neurons (layer V) from
female M5R
+/+ and M5R
2/2 mice. Golgi staining studies
revealed that cortical pyramidal neurons from female M5R
2/2
mice (4-month-old) showed no clear signs of atrophy of the basal-
dendritic tree and apical dendrites (Figure 1B). However, OVX
female M5R
2/2 mice (4-month-old) showed a similar phenotype
as male M5R
2/2 mice (Figure 1B). Immunostaining experi-
ments were carried out 2 weeks after OVX surgery and two days
after PMSG/hCG treatment on 4 month-old females. The
number of spines in basal dendrites was significantly reduced in
OVX female M5R
2/2 mice, as compared with OVX female
M5R
+/+ mice (Figure 1B) (number of spines per 10 mm length
of dendritic segment: OVX female M5R
+/+ mice, 24.460.3;
OVX female M5R
2/2 mice, 18.160.9; means6SEM; P,0.05;
n=40 dendritic segments from 3 animals per group). We also
analyzed the expression of several key neuronal receptor proteins
by using western blot analysis (cerebral cortex and hippocampus).
Specifically, we examined the expression levels of the NR1 [N-
methyl-D-aspartate (NMDA) receptor subunit], GluR1 (AMPA
receptor subunit), and GluR5 (kainate receptor subunit) gluta-
mate receptor subunits. We did not observe any significant
differences in glutamate receptor expression levels between
female M5R
2/2 and M5R
+/+ mice (4-month-old) (Figure S2).
However, OVX female M5R
+/+ mice (4-month-old) showed
significantly reduced expression levels of NR1 and GluR5
receptors in cortex and hippocampus (p,0.05; Figure S2) and
reduced expression of GluR1 in cortex, as compared to OVX
female M5R
+/+ mice. GluR1 expression levels in hippocampus
remained unaffected (Figure S2).
We next examined short time memory in female M5R
2/2
and M5R
+/+ mice, using the Y-maze spontaneous alternation
task [17]. We found that locomotor activity did not differ
significantly between the four groups (female M5R
+/+ mice,
female M5R
2/2 mice, OVX female M5R
+/+ mice, OVX female
M5R
2/2 mice; data not shown). The Y-maze test was carried
out 2 weeks after OVX surgery and two days after PMSG/
hCG treatment on 4 month-old females. In the Y-maze task,
female M5R
2/2 mice (4-month-old) showed no significant
impairments in spatial memory (Figure 1C). However, OVX
female M5R
2/2 mice (4-month-old) showed impaired sponta-
neous alternation performance, similar to the male M5R
2/2
mice [17] (p,0.05; Figure 1C).
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NO release by a muscarinic agonist and E2 in TM-BBB
cells
17b-estradiol (E2), the primary estrogen, has been reported to
signal rapidly through ERK/MAP kinase [21–23] and PI3K/Akt
[20,24] to induce eNOS activity and NO generation in peripheral
blood vessel derived cells [25,26] and in neuroblastoma cells [27].
To examine the effect of estrogen on NO release in cerebral
endothelial cells, we used the immortalized TM-BBB cell line,
which is derived from mouse brain vascular endothelial cells [28]
(See material and methods). TM-BBB cells were treated with
bethanechol (Bch; 100 mM), a muscarinic receptor agonist, and E2
(10 nM) for 0–60 min. Bch and E2 induced the phosphorylation
of ERK1/2 in a similar manner (Figure 2A,B). Moreover, both
compounds stimulated NO production by ,1.6-fold at the
180 min time point (Figure 2B). These results support the
concept that both muscarinic and estrogen receptor signaling leads
to enhanced NO production via activation of eNOS through ERK
1/2 pathways in TM-BBB cells [29–31].
RT-PCR studies showed that TM-BBB cells express M5Rs but
not M3Rs which are normally found on non-cerebral arteries
[32,33], as well as ERa,E R b and GPR30 estrogen receptors
(Figure 3A) (See material and methods). Therefore, we also
treated TM-BBB cells with selective estrogen receptor agonists,
ERa (1,3,5-Tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole (10 mM
PPT), ERb (10 mM DPN), and GPR30 (10 mM G1) for 60 min.
Subsequently, cell lysates were prepared and analyzed by western
blotting with anti-pERK or anti-total ERK antibodies. This
analysis revealed the increased ERK1/2 phosphorylation mediat-
ed by 10 mM PPT, 10 mM DPN, or 10 mM G1 for 60 min
(Figure 3B).
Figure 1. Gender-specific phenotypic differences displayed by M5R
2/2 mice. (A) First, rapid scanning for the basilar artery provide the each
portion of artery (left image; 3D angiograms of the basilar artery from female M5R
+/+ mice). Second, the vascular area of each portion of the basilar
artery was measured by the high resolution imaging within 30 min on a perpendicular section of the vessel (the site where the basilar artery enters
the circle of Wills), and mean vascular area was determined as the average of the 7 segments on the measured area of each 100 mm intervals (right
image). Ovariectomies were performed 4 months after birth using standard surgical procedures. To synchronize menstrual cycle length, we injected
pregnant mare serum gonadotropin (PMSG)/human chorionic gonadotropin (hCG) into female mice by IP injection before E2 treatment (see Materials
and Methods section). MRA was carried out 2 weeks after OVX surgery and two days after PMSG/hCG treatment on 4 month-old female M5R
+/+
(n=11) and M5R
2/2 (n=12) mice. Values are means6SE. *p,0.05. (B) Morphologic changes of cortical pyramidal neurons (layer V) from OVX female
M5R
2/2 mice. Golgi staining studies revealed that cortical pyramidal neurons from OVX female M5R
2/2 mice showed clear signs of atrophy of the
basal-dendritic tree and apical dendrites. White scale bars in upper panels, 50 mm; black scale bars in lower panels, 10 mm. (C) Performance of female
M5R
2/2 and M5R
+/+mice, as well as OVX M5R
2/2 and OVX M5R
+/+ mice, in the Y-maze spontaneous alternation task. Note that only OVX female M5R
2/2
mice showed a performance deficit in this test. Data are given as means6SEM; female M5R
+/+, n=11 mice; female M5R
2/2, n=12 mice OVX female
M5R
+/+, n=20 mice; OVX female M5R
2/2, n=20 mice; *p,0.05.
doi:10.1371/journal.pone.0005159.g001
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male M5R
2/2 and OVX female M5R
2/2 mice
MRA experiments were carried out 2 weeks after OVX surgery
and two days after PMSG/hCG treatment on 4 month-old
females. Figure 4B shows that the diameter of the basilar artery
was similar in female M5R
+/+ and M5R
2/2 mice (schematic
representation of the E2 injection and MRA monitoring schedule,
see Figure 4A). In contrast, OVX female M5R
2/2 mice showed a
significant decrease in vascular diameter, as compared to intact
female M5R
2/2 mice (Figure 4B). Moreover, treatment of OVX
female M5R
2/2 mice with E2 (1 mg E2 was injected into the tail
vein) completely prevented these deficits (Figure 3B). We noted
that PMSG/hCG treatment did not significantly affect the
diameter of the basilar artery in female mice (Figure 4B) and
E2-treated male mice (Figure S3B).
As reported previously [17], the diameter of the basilar artery
was significantly reduced in male M5R
2/2 mice, as compared to
male M5R
+/+ mice (Figure 4C). Strikingly, E2 treatment (1 mgE 2
was injected into the tail vein) of male M5R
2/2 mice led to an
increase in the diameter of the basilar artery, similar to that
observed with control male M5R
+/+ mice (Figure 4C). On the
other hand, in male M5R
+/+ mice, E2 injection had no significant
effect on vascular diameter (Figure 4C).
Normalization of neurite atrophy and cognitive function
by E2 treatment of male M5R
2/2 mice
We next examined whether the deficits displayed by male
M5R
2/2 mice could be overcome by chronic (3 weeks) E2
treatment (an 0.1 mg E2 pellet was implanted in the neck). As
expected [34], non-treated male M5R
2/2 mice (4 months old
mice) showed a significant decrease in the diameter of the basilar
artery (Figure 5B) (a schematic representation schedule of E2
tablet implantation and MRA monitoring is given in Figure 5A).
Strikingly, E2 treatment of male M5R
2/2 mice led to a recovery of
vascular diameter, similar to that of control male M5R
+/+ mice
(Figure 5B). PMSG/hCG treatment had not significant effect on
Figure 2. Bethanechol and E2 induce ERK phosphorylation and NO production in TM-BBB cells in a time-dependent manner. (A) TM-
BBB cells were stimulated with 100 mM of the muscarinic agonist, bethanechol (Bch), or 10 nM E2 for different periods of time (1–60 min), and cell
lysates were analyzed by western blotting with anti-pERK or anti-total ERK antibodies. The cumulative results of Western blot analysis are reported
from three independent experiments (10 min after treatment with Bch or E2). Values are means6SEM. *p,0.05 (vs vehicle control). (B) TM-BBB cells
were stimulated with 100 mM Bch or 10 nM E2 for different time periods. Subsequently, nitrite levels were measured in the culture medium. Values
are means6SEM. **p,0.001 (vs vehicle control).
doi:10.1371/journal.pone.0005159.g002
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PLoS ONE | www.plosone.org 4 April 2009 | Volume 4 | Issue 4 | e5159Figure 3. Agonists of ERa,E R b, and GPR30 promoted ERK activation in TM-BBB cells. (A) RT-PCR analysis demonstrating the presence of
transcripts of M3 muscarinic receptor (226 bp), M5 muscarinic receptor (230 bp), ERa estrogen receptor (453 bp), ERb estrogen receptor (204 bp) and
GPR30 estrogen receptor (386 bp) in TM-BBB cells. (B) TM-BBB cells were stimulated with the estrogen receptor agonists, PPT (ERa), DPN (ERb), or G1
(GPR30) for 60 min, and cell lysates were analyzed by western blotting with anti-pERK or anti-total ERK antibodies.
doi:10.1371/journal.pone.0005159.g003
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chronic E2 treatment experiments (Figure S3).
Hypoxic conditions affect the pH of cerebral blood serum.
However, the collection of cerebral blood serum for pH
measurements is technically very difficult in mice. The Na
+/H
+
exchanger isoform 1 (NHE1) is known to be essential for the
maintenance and regulation of pH in cortical astrocytes [35].
NHE1 is also known to slightly detectable in cortical neurons [35].
We therefore examined NHE1 expression levels in astrocytes of
fimbria hippocampus, an area enriched with GFAP positive
astrocytes. If reduced CBF causes acidosis associated with hypoxia
in the brain of male M5R
2/2 mice, NHE1 is predicted to be
upregulated in cortical astrocytes [36]. We demonstrated that
NHE1 immunolabeling was abundantly associated with plasma
membrane structures of choroid plexus between fimbria of
hippocampus and cortex (Figure 5C). In male M5R
2/2 mice,
the intensity of NHE1 immunostaining was markedly increased in
GFAP positive astrocytes in fimbria hippocampus (Figure 5C).
E2 treatment of male M5R
2/2 mice restored normal NHE1
immunostaining, similar to that of control male M5R
+/+ mice
(Figure 5C).
Normalization of astrocytic swelling in cortex and
hippocampus by E2 treatment of male M5R
2/2 mice
Under hypoxic conditions, changes in estrogen levels can lead to
astrocytic swelling in the brain [37,38]. On the basis of these
findings, we studied the number and morphology of astrocytes in
the cortex and hippocampus of E2 treated male M5R
2/2 and
M5R
+/+ mice, as well as non-treated male M5R
2/2 and M5R
+/+
mice. We found that non-treated male M5R
2/2 mice showed a
significant increase in the number of GFAP positive cells in cortex
(Figure 4A) and hippocampus (Figure 4A, Figure S4A–C), but
the number of S100b positive astrocytes, a measure of the total
number of astrocytes, remained unchanged. Furthermore, GFAP
positive astrocytes in non-treated male M5R
2/2 mice showed
many astrocytic processes (Figure S4C). However, male M5R
2/2
mice did not show migration of microglia (Iba-1 or Mac-2 positive
cells) in cortex and hippocampus (Figure S4C). To examine the
intactness of the blood brain barrier (BBB), we injected 25 mg/kg
Evans blue (EB) into the tail vain of 6-month-old male M5R
2/2
and M5R
+/+ mice, followed by visualization of auto-fluorescence
of EB in cortical tissue [39]. Since EB binds to albumin, red
fluorescence of EB observed in tissue indicates leakage of blood
Figure 4. E2 injection completely restores the cross-sectional area of the basilar artery in male M5R
2/2 mice as well as in OVX
female M5R
2/2 mice. (A) Schematic representation of the E2 injection and MRA monitoring schedule used. (B) Vascular area of the basilar artery in
female M5R
+/+, M5R
2/2, OVX M5R
+/+, OVX M5R
2/2, and E2 injected OVX M5R
+/+and M5R
2/2 mice. MRA was carried out 2 week after OVX surgery on 4
month-old female M5R
+/+ (n=15) and M5R
2/2 (n=15) mice. MRA was carried out 2 week after OVX surgery and two days after PMSG/hCG treatment
on 4 month-old female M5R
+/+ (n=14) and M5R
2/2 (n=14) mice. After MRA analysis, 1 mg E2 was injected into the tail vein, followed by MRA 30 min
after injection. Values aremeans6SE. **p,0.001. (C)Vascular area of the basilarartery in male M5R
+/+andM5R
2/2 mice andE2 injected male M5R
+/+ and
M5R
2/2 mice. 3.5–4.5 month-old male M5R
+/+ (n=6) and M5R
2/2 (n=10) mice were used for MRA analysis and 1 mg E2 was injected into the tail vein,
followed by MRA 30 min after injection. Values are means6SEM. **p,0.001.
doi:10.1371/journal.pone.0005159.g004
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detected in cortex and hippocampus of male M5R
2/2 and M5R
+/+
mice (Figure S4E). These data suggest that astrocytic swelling in
male M5R
2/2 brain is unlikely to be associated with inflammation
around cortical or hippocampal blood vessels. Moreover, non-
treated female M5R
2/2 mice did not show a significant increase in
the number of GFAP positive cells in cortex and hippocampus
compared to female M5R
+/+ mice (4 months old; Figure 6A).
However, 4-month-old OVX female M5R
2/2 mice showed
activated GFAP positive astrocytes in cortex and hippocampus
(Figure 6A), similar to male M5R
2/2 mice (Figure 6B, Figure
S4A–C) (morphological analysis was carried out 2 weeks after OVX
surgery on 4 month-old female M5R
+/+ and M5R
2/2 mice),
suggesting that female sex hormones, such as estrogen, may be able
tocompensatefortheastrocyteactivation causedbythe impairment
of cerebrovascular function. Strikingly, E2 treatment (an 0.1 mg E2
pellet was implanted in the neck) of male M5R
2/2 mice restored
normal GFAP expression levels (Figure 6B, Figure S4B). On the
other hand, E2-treated male M5R
+/+ control mice showed similar
levels of GFAP expression in cortex and hippocampus as non-
treated M5R
+/+ mice (Figure 6B, Figure S4A,B).
To exclude the possibility that E2 treatment upregulates GFAP
gene expression levels in male M5R
2/2 mice, we carried out
morphological studies on CA3 hippocampal astrocytes using
three-dimensional reconstruction of electron microscope images
(Figure 6C). A total of 100–110 sections of 70 nm electron
microscope images were reconstructed to visualize astrocyte
shapes (see three-dimensional reconstruction of electron micro-
scope images in Supplemental movies; non-treated male M5R
+/+
mice, Movie S1; non-treated male M5R
2/2 mice, Movie S2;
E2-treated male M5R
+/+ mice, Movie S3; E2-treated male
M5R
2/2 mice Movie S4). This analysis showed that the astrocyte
activation leaded to the swollen astrocyte foot processes in male
M5R
2/2 mice were markedly reduced in E2-treated male M5R
2/2
mice (Figure 6C). It is therefore unlikely that E2 treatment leads to
changes in gfap gene expression levels in male M5R
2/2 mice.
Normalization of neural morphology in cortex and
hippocampus by E2 treatment of male M5R
2/2 mice
We examined the effect of chronic (3 weeks) E2 treatment on
astrocyte morphological changes. As expected, non-treated male
M5R
2/2 mice (4 months old) showed a significant reduction in
spine number in cortical (Figure 7A,B) and CA3 hippocampal
pyramidal neurons (Figure 7C), and synapse number in CA3
hippocampal pyramidal neurons (Figure 7D). However, after 3
weeks of E2 treatment, these morphological deficits were greatly
ameliorated (Figure 7A–D).
We also examined the effect of chronic E2 treatment on the
performance of male M5R
2/2 and M5R
+/+ mice in the Y-maze
spontaneous alternation test which is commonly employed to
assess spatial working memory. As reported previously, male
M5R
2/2 mice (4 months old) showed pronounced deficits in
spontaneous alternation performance (p,0.05; Figure 7D), as
compared to male M5R
+/+ mice. After chronic E2 treatment, male
M5R
2/2 mice did no longer show any significant impairments in
this task (Figure 7D), indicating that E2 enhances cognitive
function in male M5R
2/2 mice.
Discussion
The therapeutic utility of estrogen in postischemic treatment
paradigms has been studied using chronic cerebral hypoperfusion
models. E2 administered after permanent middle cerebral artery
occlusion or reversible middle cerebral artery occlusion reduces
infarction size in ovariectomized female rats [40–42]. In these
studies, estrogen is thought to act as a cerebral vasodilator and to
protect vascular integrity. However, surgically induced animal
models of cerebral hypoperfusion also lead to neuronal death and
Figure 5. Chronic E2 treatment rescues cerebrovascular deficits in male M5R
2/2 mice. (A) A schematic representation schedule of E2 tablet
implantation and MRA monitoring. (B) Chronic E2 treatment completely rescues cerebrovascular deficits in 3.5 month-old male M5R
2/2 mice. After
MRA, an E2 tablet (0.1 mg / 21 days release) was implanted into the neck of each mouse, followed by MRA testing 3 weeks after the start of E2
administration. (C) The increased NHE1 expression levels in male M5R
2/2 mice. Na
+/H
+ exchanger isoform 1 (NHE1)is indicated by Red color. The
GFAP is indicated by Green color. The site where the choroid plexus between fimbria of hippocampus and ventricle is indicated by arrows. Scale bar;
100 mm.
doi:10.1371/journal.pone.0005159.g005
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reduction of infarction size seen in these models may be caused by
anti-inflammatory or anti-apoptotic activities of E2 [43,44]. Thus,
M5R
2/2 mice represent a novel genetic model of chronic cerebral
hypoperfusion that can provide new insight into beneficial effects
of estrogen in the absence of necrotic or inflammatory processes.
We demonstrated that male M5R
2/2 mice displayed a
significantly increased immunostaining of GFAP positive cells in
cortex and hippocampus, indicative of astrocytic activation. One
possibility is that this defect is responsible for the dendritic atrophy
and loss of neural functions in these regions displayed by male
M5R
2/2 mice. These findings suggest that male M5R
2/2 mice
represent a novel model to study the physiological and
pathophysiological roles of the central cholinergic vasodilator
system in regulating CBF, reactive astrocytic swelling and
cognitive processes.
Strikingly, the phenotypic changes displayed by male M5R
2/2
mice were not observed in female M5R
2/2 mice, suggesting that
female sex hormones might modulate CBF in female M5R
2/2
mice. Consistent with this notion, we observed that estrogen (E2)
was able to release NO from cerebral vascular endothelial cells
(NO is predicted to trigger vasodilation and increase CBF).
To test the hypothesis that estrogen may rescue the phenotypic
deficits displayed by male M5R
2/2 mice, we implanted estrogen
Figure 6. Male M5R
2/2 mice exhibit astrocyte swelling which is rescued by E2 treatment. (A) Female M5R
2/2 mice exhibit GFAP
immunoreactivity similar to female M5R
+/+ mice in the cortex and the CA3 region of hippocampus. Immunostaining experiments were carried out 2
weeks after OVX surgery and two days after PMSG/hCG treatment on 4 month-old females. OVX M5R
2/2 female mice showed a significantly
increased immunoreactivity of GFAP positive cells. Scale bar=1 mm. (B) GFAP immunostaining shows astrocyte activation in cortex and
hippocampus in 4-month-old male M5R
2/2 mice. However, E2 treatment of male M5R
2/2 mice restored normal GFAP expression levels. Frozen
sections of the brain (coronal section) were prepared from male M5R
2/2 and M5R
+/+ mice without or after chronic E2 treatment (3 weeks, 1 mg E2 was
injected into the tail vein). For details, see the legend to Fig. 3D. Scale bar=1 mm. (C) Astrocytic swelling in the CA3 hippocampal astrocytes was
visualized using three-dimensional reconstruction of electron microscope images. A total of 100–110 sections of 70 nm electron microscope images
were reconstructed to visualize astrocytic shapes.
doi:10.1371/journal.pone.0005159.g006
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2/2 mice, and initially
performed MRA measurements on the basilar artery three weeks
post-implantation. We found that the diameter of the basilar artery
was restored to normal in male M5R
2/2 mice treated with
estrogen. Several studies have shown that M5Rs are expressed by
cerebral endothelial cells [9,10]. Estrogen receptors (ERs) have
also been shown to be expressed by vascular endothelial and
smooth muscle cells [45,46]. Estrogen binding to membrane-
bound ERs can lead to the activation of G proteins such as Gs and
Gq [47,48]. M5Rs and ERs may therefore be linked to common
signaling pathways in cerebral endothelial cells. The observed
rapid activation of MAPKs by E2 in TM-BBB cells may therefore
reflect the activation of membrane-bound ERs linked to G protein
signaling pathways. Consistent with this concept, the novel
membrane estrogen receptor GPR30 [29–31] was also detected
in the TM-BBB cell line (Figure 3A). We found that PPT (an
ERa agonist), DPN (an ERb agonist), and G1 (a GPR30 agonist)
promoted ERK activation (Figure 3B). Therefore, a combination
of estrogen receptors, ERa,E R b, and GPR30, may allow for
sufficient ERK1/2 phosphorylation.
E2-mediated NO production has been linked to vasodilation
and is thought to involve stimulation of eNOS following rapid
activation of phosphatidylinositol-3 kinase (PI3K)/Akt or MAPK
signaling in different vascular tissues [20,21,25,49].
Figure 7. E2 restores normal morphology in cortical and hippocampal pyramidal neurons from male M5R
2/2 mice. (A) Morphologic
changes of cortical pyramidal neurons (layer V) from male M5R
2/2 mice without or after chronic E2 treatment (3 weeks). Golgi staining revealed that
cortical pyramidal neurons from male M5R
2/2 mice showed clear signs of atrophy of the basal-dendritic tree and apical dendrites. E2 treated male
M5R
2/2 mice showed a similar morphology of spines in the basal-dendritic tree and apical dendrites as M5R
+/+ control mice. (B) Number of spines per
10 mm length of dendritic segment of cortical pyramidal neurons (layer V) from male M5R
2/2 and M5R
+/+ mice, and E2 treated male M5R
2/2 and
M5R
+/+ mice. N=40 dendritic segments from 5 animals per group. (C) Number of spines per 10 mm length of dendritic segment of CA3 hippocampal
pyramidal neurons from male M5R
2/2 and M5R
+/+ mice, and E2 treated male M5R
2/2 and M5R
+/+ mice. Hippocampal neurons from male M5R
2/2
mice exhibited a significantly reduced number of dendritic spines. E2 administration also restored the number of dendritic spines in the CA3
hippocampus. N=20 dendritic segments from 5 animals per group. Values are means6SEM. **p,0.001. (D) The number of synapses per 10
2 mm was
counted in the CA3 hippocampus by analyzing electron microscope images. A total of 100–110 sections of 70 nm electron microscope images were
counted for each sample. Values are means6SEM. **p,0.001. (E) Performance of male M5R
+/+ and M5R
2/2 mice prior to and after chronic E2
treatment in a Y-maze spatial-memory test. Chronic E2 tablet (0.1 mg / 21 days release) treatment completely rescues cerebrovascular and cognitive
deficits in male M5R
2/2 mice. All studies were carried out with 3 month-old male M5R
+/+ (n=16) and M5R
2/2 (n=14) mice. Values are means6SEM.
*p,0.05, **p,0.001.
doi:10.1371/journal.pone.0005159.g007
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M5R
2/2 mice, in contrast to non-OVX female M5R
2/2 mice,
suffer from a constitutive constriction of cerebral arteries, reduced
CBF, dendritic atrophy (Figure 1A), and short-term memory loss
(Figure 1C). We also found that E2 injection completely restored
the diameter of the basilar artery in OVX female M5R
2/2 mice
(as compared to non-OVX female M5R
2/2 mice). E2 partially
restored the vascular area in OVX female M5R
+/+ mice (as
compared to non-OVX female M5R
+/+ mice). In addition, E2
rescued the constitutive constriction of the basilar artery in male
M5R
2/2 mice. These results suggest that estrogen (E2) can
compensate for the lack of M5R-mediated vasodilation in cerebral
blood vessels in M5R
2/2 mice. M5R
2/2 mice can therefore be
used as novel model to examine the vasodilator effects of estrogen
in vivo. Therefore, estrogen therapy may be clinically useful not
only for female but also for male patients suffering from
cerebrovascular deficits.
It is known that ischemia results in a marked reduction of tissue
pH [50] and cerebral ischemia has been demonstrated to produce
an intracellular acidosis in the ischemic core as well as in the
ischemic penumbra [51]. For example, the NHE1 is one of the
major acid extrusion mechanisms after intracellular acidosis.
NHE1 catalyzes the electroneutral exchange of H
+ and Na
+ ions
across cellular membranes, thereby regulating the pH of the
cytoplasm [52,53]. Therefore, expression of NHE1 is thought to
protect cells from internal acidification and to regulate cell volume
in response to hypoxia. We found significantly increased NHE1
expression levels in male M5R
2/2 mice (Figure 5C). Swollen
astrocyte foot processes lead to changes in brain extracellular space
volume, composition, and geometry in aged animals with severe
learning impairment [49]. It is hypothesized that the degree of
hippocampal learning impairment in aged animals is related to
astrocyte swelling [49]. Therefore we speculated that hypoxic
stimulation induced astrocyte activation might contribute to the
changes of neural activity in brain of male M5R
2/2 mice. We
found that the lack of M5Rs in male mice was associated with
cortical and hippocampal astrocytic swelling and deficits in
dendritic morphology. It is well known that changes in astrocyte
function regulate synaptic transmission [54–57]. It is tempting to
speculate that the astrocytic swelling phenotype observed with
male M5R
2/2 mice is a consequence of cerebrovascular
insufficiency. Strikingly, E2 treatment of male M5R
2/2 mice led
to a reversal of the astrocytic swelling phenotype, which can
occupy extra-synaptic spaces (Figure 6C), and restored normal
numbers of dendritic spines of pyramidal neurons in cortical and
hippocampal pyramidal neurons (Figure 7A–D). Treatment with
E2 also improved the performance of male M5R
2/2 mice in a
cognitive test (Y-maze spontaneous alternation task)(Figure 7E).
Estrogen treatment did not affect GFAP expression levels in male
M5R
+/+ mice, as studied by western blotting analysis (Figure
S4B). It is therefore unlikely that E2 acts on astrocytes directly to
reduce GFAP immunoreactivity. GFAP expression levels were
strikingly correlated with NHE1 expression levels in astrocytes,
probably as a consequence of the hypoxic state of the brain of
male M5R
2/2 mice. Our findings support the idea that E2
regulates important neuroprotective mechanisms in vivo by acting
directly on endothelial cells and/or through glial cell intermedi-
aries. Estrogen has been demonstrated to have numerous effects
on glial cells and neurons. Besides affecting CBF by acting on
vascular ERs, E2 may protect against neuronal damage through
actions on glial cell activation [36,37]. Furthermore, animal
studies suggest that E2 has neuroprotective effects against excito-
toxicity [58], oxidative damage [59], and cerebral ischemia [60].
Our observations support the concept that the beneficial effects of
estrogen on neural function observed in the present study are due
to cerebral vasodilation controlling astrocyte activation as well as a
direct neuroprotective effect. Clearly, additional studies are
needed to examine the causal relationship between the cerebro-
vascular, neuromorphological, and behavioral deficits displayed by
male M5R
2/2 mice and to further explore the mechanisms
underlying the ability of estrogen to reverse these phenotypes.
Materials and Methods
Animals
M5R
2/2 mice were produced as described previously [9]. The
average menstrual cycle length is 4 days in mice. To synchronize
menstrual cycle length, we injected pregnant mare serum
gonadotropin (PMSG)/human chorionic gonadotropin (hCG)
into female mice by intraperitoneal (IP) injection before E2
treatment. Female mice were primed with an IP injection of
7.5 IU of PMSG and 7.5 IU of hCG to induce ovulation. After
two days, female mice were subjected to the experiments. Animal
experiments were approved by the Animal Experiment Commit-
tee of the RIKEN Brain Science Institute.
Measurement of CBF using a laser Doppler flowmeter
CBF measurements were performed as previously described
[17]. The branches of the MCA were defined in the order from A1
to A3 [17]. A probe with a diameter of 0.5 mm was attached to
the point of divergence of the MCA, and CBF was measured
continuously in the parietal lobe using a laser Doppler flowmeter
(ALF 21, Advance Co., Ltd, Tokyo), in conjunction with a
PowerLab system (AD Instruments, CA, USA).
MRA analysis
MRA was performed as previously described [17], with minor
modifications. Mice were anesthetized with pentobarbital and
subjected to micro-MRI scans using a vertical bore 9.4 T Bruker
AVANCE 400WB imaging spectrometer with a 250 mT/m
actively shielded microimaging gradient insert (Bruker BioSpin
GmbH, Ettlingen, Germany) [17]. A 25-mm resonator was used
for signal excitation and detection. The depth of anesthesia was
monitored with a breathing sensor, and was maintained with 0.5
to 1.5% isoflurane in air (2 l/min flow rate). Two-dimensional
horizontal MRA images were acquired by using a method derived
from gradient-echo pulse sequence with flow compensation. The
scans were performed with the following imaging parameters:
TR=50.0 ms; TE=5.0 ms; flip angle=25u; matrix=256?256;
field of view=2?2c m
2; number of slices=40; slice thick-
ness=0.05 mm; and total imaging time=51 min (10 averages).
Angiograms were obtained by generating maximum intensity
projections using Paravision software (Bruker BioSpin GmbH).
Basilar arterial vascular area was measured on the perpendicular
section of the vessel using OSIRIX software, and mean vascular
dimension was determined as the average of 7 segments in the
measured area (Fig. 3A).
Ovariectomy and E2 implantation
Ovariectomies were performed 4 months after birth using
standard surgical procedures. MRA was carried out 2 weeks after
OVX surgery on 4 month-old female M5R
+/+ and M5R
2/2 mice.
For transient E2 treatment experiments, 1 mg E2 was injected into
the tail vein. For the chronic administration (3 weeks) of estrogen
pellets (steady-release pellet of an 0.1 mg 17b-estradiol pellet) to
adult male mice, a small incision was made in the dorsal neck
region for the insertion of the hormone pellet (Innovative
Research) to maintain plasma estrogen levels ranging from 250
Beneficial Effects of Estrogen
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under anesthesia. The doses used in these experiments were
chosen based upon their ability to generate physiological serum
concentrations [19]. Estrogen was below the level of detection
prior to E2 treatment of male mice.
Cell culture
The conditionally immortalized mouse brain capillary endo-
thelial cell line (TM-BBB) was performed as previously described
[61]. The culture medium used consisted of DMEM (Gibco,
Carlsbad, CA) supplemented with 15 mg/ml endothelial cell
growth factor (Roche Diagnostics, Indianapolis, IN), 100 U/ml
benzylpenicillin potassium, 100 mg/ml streptomycin sulfate, and
10% fetal bovine serum.
Immunoblotting
TM-BBB cells were seeded at a density of 6.5610
4 cells per dish
on collagen type I-coated 35-mm culture dishes (Becton
Dickinson). After 48 h of culture, cells were incubated for 24 h
in growth factor-free medium followed by 2 h incubation in
serum-free fresh medium at 33 uC. TM-BBB cells were incubated
at 33 uC with vehicle, bethanechol 100 mM (Bch: MP Biomedicals,
Solon, OH) or 17-b-estradiol 10 nM (E2: Sigma Chemical Co.) as
indicated. TM-BBB cells were also treated with selective activators
of ERa (1,3,5-Tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole; PPT,
Sigma), ERb (DPN, Tocris Bioscience), and GPR30 (G1,
MERCK). Cells were rinsed with ice-cold phosphate-buffered
saline (PBS) containing 0.5 mM Na3VO4 and then collected in
100 ml of lysis buffer (50 mM Tris-HCl, pH 7.5, containing
150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.2 mM
Na3VO4, 1 mM EGTA, 0.4 mM EDTA, 1 mg/ml of aprotinin
and leupeptin, and 0.1 mg/ml of phenylmethylsulphonyl fluoride).
Lysates were centrifuged at 10,000 g for 15 min at 4uC to remove
insoluble material and normalized for protein content. Equal
amounts of protein (20 mg) were separated by 10% SDS–PAGE,
transferred to nitrocellulose membranes (Schleicher & Schuell),
probed with rabbit polyclonal phospho-p44/42 MAP kinase
antibody or rabbit polyclonal p44/42 MAP kinase antibody (Cell
Signaling Beverly, MA). Subsequently, the membranes were
incubated with goat anti-rabbit IgG secondary antibodies
(PerkinElmer Life Sciences Inc. Boston, MA).
RT-PCR
Total RNA was extracted from tissues derived from TM-BBB
using Trizol reagent (GIBCO). After DNase treatment (2 units ml
21;
Ambion), total RNA (<1 mg) was reverse-transcribed by using oligo
(dT)16 primers and murine leukemia virus RT (Perkin–Elmer),
followed by PCR amplification of a DNA segment specific for each
receptor gene (PCRconditions: 98uC for 2 min; 35 cycles of 98uCf o r
10 sec and 55uC for 30 sec; 72uC for 5 min). For PCR amplification
for the ER alpha gene, 59-TGGCGCTCCATGGAACAC-39 and
59-CATCTCCAGGAGCAGGTC-39; ER beta gene, 59-AAAGC-
CAAGAGAACCAGTGGGCAC-39 and 59-GCCAATCATGTG-
CACCAGTTCCTT-39;G P R 3 0g e n e ,5 9-ATCTGGATGGCCT-
CAGTGTC-39 and 59-ACTATGTGGCCTGTCAAGGG-39;M 3
receptor gene, 59-ACCAAGACCACAGTAGCAGTG-39 and 59-
CTCTCTACATCCATAGTCCC-39; M5 receptor gene, 59-
GTCTCCGTCATGACCATACTCTA-39 and 59-CCCGTTGT-
TGAGGTGCTTCTAC-39
Nitrite assay
NO production was determined by measuring nitrite accumu-
lation in culture medium using the NO2/NO3 Assay Kit-FX
(Dojindo Laboratories, Kumamoto, Japan) according to manu-
facturer’s instructions. Briefly, TM-BBB cells were seeded at a
density of 6610
4 cells per dish on collagen type I-coated 24 well
plates (IWAKI, Chiba, Japan). After 48 h of culture, cells were
washed twice with phenol red-free and serum-free MEM (Gibco)
followed by incubation in 300 ml of the same medium containing
vehicle, Bch or E2. After this incubation period, 300 ml of medium
were removed from each well and centrifuged at 1,000 g for
15 min at room temperature. Supernatants (80 ml aliquots) were
mixed with 20 ml of Buffer solution (pH 7.6) and 10 mlo f
fluorescence reagent (2,3-Diaminonaphthalene) solution, followed
by incubation for 30 min at room temperature. The reaction was
terminated by the addition of 30 ml of Stop solution. Fluorescence
was measured using a spectrofluorometer (ARVO MX, PerkinEl-
mer Life Sciences Inc.), with excitation and emission wavelengths
set at 355 and 460 nm, respectively
Immunohistochemistry and Golgi staining
Frozen cryosections (15 mm) were treated with 3% H2O2,
incubated with blocking buffer (PBS containing 0.01% Triton and
1.5% normal goat serum), and incubated overnight at 4uC with
primary antibodies. Sections were incubated with secondary
antibody in blocking buffer for 1 h at room temperature. The
primary antibodies used were anti-GFAP Ab (DAKO), anti-Iba-1
(Wako, Japan), and anti-Mac-2 (American Type Culture Collec-
tion, USA). Secondary antibodies were alexa fluor 546 goat anti-
mouse IgG (Molecular Probes) and alexa fluor 488 goat anti-rabbit
IgG (Molecular Probes). Sections were counterstained with
Hoechst (CALBIOCHEM). Golgi staining was performed essen-
tially as described previously [17]
Electron microscopy
For electronmicroscopic observation of astrocytes in the CA3
region of the hippocampus, a M5R
2/2 mouse and a wild-type
control mouse were fixed 2.5% glutaraldehyde and 4% parafor-
maldehyde. After fixation, the tissue samples were postfixed with
1% (w/v) osmium tetroxide in 0.1 M PB, dehydrated in a graded
ethanol series, and embedded in epoxy resin (EPON812, TAAB,
Aldermaston, UK). For electron microscopic observations, the
brain was sectioned into a series of 100–110 sections (70 nm thick)
with an ultramicrotome (EM UC6, Leica, Heidelberg, Germany).
Ultrathin sections were stained with uranyl acetate and lead
citrate. Electron micrographs recorded on imaging plates through
a JEM-1200EX electron microscope (JEOL DATUM LTD.,
Tokyo, Japan) were scanned and digitized by an FDL 5000
imaging system (Fuji Photofilm, Tokyo, Japan). To reconstruct 3D
images of astrocytes, each series was aligned using sEM Align
software and edges of astrocytic cytoplasm were traced using IGL
Trace software based on ref. [62] (freely available at http://
synapse-web.org/tools/reconstruct/reconstruct.stm).
Y-maze test
The Y-maze task was performed essentially as described
previously [17].
Statistical Analysis
Data are expressed as mean6SEM. Statistical comparisons of
CBF, nitrite, and MRA data were performed using Student’s t-test
or ANOVA. p,0.05 was considered to be statistically different.
Supporting Information
Figure S1 Gender-specific phenotypic differences in CBF
displayed by M5R2/2 mice. CBF was measured in the middle
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in the order from A1 to A3 for classification scheme, described
[17]. CBF was measured in the A1 area by laser-Doppler
flowmetry. Male M5R2/2 mice showed significantly reduced
CBF, as compared to male M5R+/+ mice. In contrast, female
M5R+/+ and M5R2/2 mice displayed similar CBF. OVX
female M5R2/2 mice showed reduced CBF, similar to male
M5R2/2 mice. Data are expressed as CBF relative to M5R+/+
(white bars). OVX mice were used for CBF measurements 4 weeks
after surgery performed on 4-month-old female M5R2/2 and
M5R+/+ mice. The numbers given in parentheses under the bars
indicate the number of independent experiments (mice). Data are
means6SEM. **p,0.001 (vs M5R+/+ mice).
Found at: doi:10.1371/journal.pone.0005159.s001 (11.24 MB
DOC)
Figure S2 Gender-specific phenotypic differences displayed by
female M5R2/2 mice. Relative expression levels, determined by
Western blot analysis, of cortical (top panel) and hippocampal
(lower panel) glutamate receptor subunits in female M5R2/2
and M5R+/+ (=100%) mice, and OVX M5R2/2 and OVX
M5R+/+ (=100%) mice. The numbers given in parentheses
underneath the bars indicate the number of independent
experiments (mice). Data represent means6SEM; *p,0.05;
**p,0.001.
Found at: doi:10.1371/journal.pone.0005159.s002 (11.24 MB
TIF)
Figure S3 PMSG/hCG treatment did not significantly affect the
diameter of the basilar artery in male mice. (A) Experimental
schedule for PMSG/hCG/E2 treatment experiments. (B) PMSG/
hCG treatment did not affect the diameter of the basilar artery
during transient or chronic E2 treatment experiments. All studies
were carried out with 3 month-old male M5R+/+ and M5R2/2
mice (n=12 per group). Data represent means6SEM; *p,0.05;
**p,0.001.
Found at: doi:10.1371/journal.pone.0005159.s003 (9.00 MB TIF)
Figure S4 Male M5R2/2 mice exhibit astrocyte activation
without migration of microglia. Frozen sections of cerebral cortex
and hippocampus were prepared from 4-month-old male M5R+/
+ and M5R2/2 mice. An E2 tablet (0.1 mg/21 days release) was
implanted into neck of each mouse. (A) GFAP immunostaining
signals in the hippocampal CA3 region from E2-treated male
M5R2/2 and M5R+/+ mice vs. non-treated male M5R2/2
mice. Scale bar=200 mm. (B) E2 treatment of male M5R2/2
mice restored wild-type-like GFAP protein expression levels in the
hippocampus, as studied by western blotting analysis. E2-treated
male M5R+/+ mice showed similar GFAP protein expression
levels as non-treated male M5R+/+ mice. Data are means6SEM
(n=8 per group). *p,0.05 (vs M5R+/+ mice). (C) Male M5R2/
2 mice showed a significantly increased number of GFAP positive
cells in the CA3 region of the hippocampus. However, the number
of S100b positive astrocytes, a measure of the total number of
astrocytes, remained unchanged. Five hippocampal CA3 sections
from 5 animals per group were analyzed. Values are means6SE.
**p,0.001. (D) Vimentin and neurocan, markers for injured
astrocytes, did not show any increase in immunoreactivity in male
M5R2/2 mice. Scale bar, 1 mm. (E) Leakage of EB in
surrounding blood vessels was not detected in cortex and
hippocampus of male M5R2/2 and M5R+/+ mice. Scale bar,
1 mm.
Found at: doi:10.1371/journal.pone.0005159.s004 (11.24 MB
TIF)
Movie S1
Found at: doi:10.1371/journal.pone.0005159.s005 (0.96 MB
SWF)
Movie S2
Found at: doi:10.1371/journal.pone.0005159.s006 (1.90 MB
SWF)
Movie S3
Found at: doi:10.1371/journal.pone.0005159.s007 (2.04 MB
SWF)
Movie S4
Found at: doi:10.1371/journal.pone.0005159.s008 (1.85 MB
SWF)
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